SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Biallelic Loss-of-Function NDUFA12 Variants Cause a Wide Phenotypic Spectrum from Leigh/Leigh-Like Syndrome to Isolated Optic Atrophy.

Magrinelli, F; Cali, E; Braga, VL; Yis, U; Tomoum, H; Shamseldin, H; Raiman, J; Kernstock, C; Rezende Filho, FM; Barsottini, OGP; et al. Magrinelli, F; Cali, E; Braga, VL; Yis, U; Tomoum, H; Shamseldin, H; Raiman, J; Kernstock, C; Rezende Filho, FM; Barsottini, OGP; Taylor, RW; Østergaard, E; Tamim, A; Schäferhoff, K; Sallum, JMF; Zaki, MS; Kok, F; Bhatia, KP; Wissinger, B; Sergeant, K; Haack, TB; Horvath, R; Hiz, S; Alkuraya, FS; Houlden, H; Pedroso, JL; Maroofian, R (2022) Biallelic Loss-of-Function NDUFA12 Variants Cause a Wide Phenotypic Spectrum from Leigh/Leigh-Like Syndrome to Isolated Optic Atrophy. Mov Disord Clin Pract, 9 (2). pp. 218-228. ISSN 2330-1619 https://doi.org/10.1002/mdc3.13398
SGUL Authors: Maroofian, Reza

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (960kB) | Preview
[img] Microsoft Word (.docx) (Table S1) Published Version
Available under License Creative Commons Attribution.

Download (37kB)

Abstract

BACKGROUND: Biallelic loss-of-function NDUFA12 variants have hitherto been linked to mitochondrial complex I deficiency presenting with heterogeneous clinical and radiological features in nine cases only. OBJECTIVES: To fully characterize, both phenotypically and genotypically, NDUFA12-related mitochondrial disease. METHODS: We collected data from cases identified by screening genetic databases of several laboratories worldwide and systematically reviewed the literature. RESULTS: Nine unreported NDUFA12 cases from six pedigrees were identified, with presentation ranging from movement disorder phenotypes (dystonia and/or spasticity) to isolated optic atrophy. MRI showed basal ganglia abnormalities (n = 6), optic atrophy (n = 2), or was unremarkable (n = 1). All carried homozygous truncating NDUFA12 variants, three of which are novel. CONCLUSIONS: Our case series expands phenotype-genotype correlations in NDUFA12-associated mitochondrial disease, providing evidence of intra- and inter-familial clinical heterogeneity for the same variant. It confirms NDUFA12 variants should be included in the diagnostic workup of Leigh/Leigh-like syndromes - particularly with dystonia - as well as isolated optic atrophy.

Item Type: Article
Additional Information: © 2021 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC. on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Leigh syndrome, NDUFA12, dystonia, optic atrophy, phenotypic heterogeneity, NDUFA12, dystonia, optic atrophy, Leigh syndrome, phenotypic heterogeneity
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Mov Disord Clin Pract
ISSN: 2330-1619
Language: eng
Dates:
DateEvent
2 February 2022Published
3 January 2022Published Online
11 December 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
G0601943Medical Research CouncilUNSPECIFIED
MR/S005021/1Medical Research CouncilUNSPECIFIED
MR/S01165X/1Medical Research CouncilUNSPECIFIED
2121053Research Advisory Council - RiyadhUNSPECIFIED
WT093205MAWellcome Trusthttp://dx.doi.org/10.13039/100004440
WT104033AIAWellcome Trusthttp://dx.doi.org/10.13039/100004440
203105/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
418081722Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
433158657Deutsche Forschungsgemeinschafthttp://dx.doi.org/10.13039/501100001659
109915/Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/N025431/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/V009346/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
309548European Research Councilhttp://dx.doi.org/10.13039/501100000781
MR/N027302/1Newton FundUNSPECIFIED
G100142Addenbrooke's Charitable Trust, Cambridge University Hospitalshttp://dx.doi.org/10.13039/501100002927
MR/S005021/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
BRC-1215-20014National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
PubMed ID: 35141356
Web of Science ID: WOS:000737263300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114576
Publisher's version: https://doi.org/10.1002/mdc3.13398

Actions (login required)

Edit Item Edit Item